出典(authority):フリー百科事典『ウィキペディア(Wikipedia)』「2015/10/28 15:24:26」(JST)
Systematic (IUPAC) name | |
---|---|
2-[(3S)-3-{[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino}-
|
|
Clinical data | |
Trade names | Lotensin |
AHFS/Drugs.com | monograph |
MedlinePlus | a692011 |
Pregnancy category |
|
Legal status |
|
Routes of administration |
Oral |
Pharmacokinetic data | |
Protein binding | 96.7% |
Metabolism | Hepatic glucuronidation |
Biological half-life | 10-11 hours |
Excretion | Renal and biliary |
Identifiers | |
CAS Registry Number | 86541-75-5 Y |
ATC code | C09AA07 |
PubChem | CID: 5362124 |
IUPHAR/BPS | 6374 |
DrugBank | DB00542 Y |
ChemSpider | 4514935 Y |
UNII | UDM7Q7QWP8 Y |
ChEBI | CHEBI:3011 Y |
ChEMBL | CHEMBL838 Y |
Chemical data | |
Formula | C24H28N2O5 |
Molecular mass | 424.49 g/mol |
SMILES
|
|
InChI
|
|
Y (what is this?) (verify) |
Benazepril, brand name Lotensin (Novartis), is a drug of the angiotensin-converting enzyme (ACE) inhibitor class used primarily in treatment of hypertension, congestive heart failure, and heart attacks, and also in preventing renal and retinal complications of diabetes. Its indications, contraindications, and side effects are as those for all ACE inhibitors. The drug is a precursor of the active agent, which is metabolized by the liver into its active form. Upon cleavage of its ester group, benazepril is converted into benazeprilat, its active form, which is a nonsulfhydryl ACE inhibitor.
Patients with advanced renal insufficiency taking benazepril show "substantial" kidney benefits.[1] A long-term study of patients' kidney disease revealed patients who took benazepril had better kidney function and slower progressions of kidney disease than their peers who took a placebo drug.[2] This is notable because this category of pharmaceuticals has long been thought to cause further kidney damage or increase the rate of progression for kidney disease.
According to coverage of the study on WebMD: "ACE inhibitors can pose a potential threat to kidneys, as well. The key question was whether damaged kidneys would worsen if patients took ACE inhibitors. In a nutshell, concerns centered on blood levels of potassium and creatinine, waste products that are excreted by the kidneys. Testing creatinine levels in the blood is used as a way to monitor kidney function (...) kidney problems worsened more slowly in those taking Lotensin. Overall, there were no major differences in side effects between patients taking Lotensin or the placebo.[2]" This study marks the first indication that benazepril, and perhaps other ACE inhibitors, may actually be beneficial in the treatment of hypertension in patients with kidney disease.
The most common side effects patients experience are a headache or a chronic cough. The chronic cough develops in about 20% of patients treated,[3] and those patients that experience it find it develops after a few months of use. Anaphylaxis, angioedema, and elevation of potassium levels are more serious side effects that can also occur.
Benazepril should be discontinued during pregnancy, as it can harm the fetus.
It is also available in combination with hydrochlorothiazide, under the trade name Lotensin HCT', and with amlodipine (trade name Lotrel).
Under the brand names Fortekor (Novartis) and VetACE (Jurox Animal Health),[citation needed] benazepril hydrochloride is used to treat congestive heart failure in dogs[4][5] and chronic renal failure in dogs and cats.[citation needed]
|
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
リンク元 | 「ベナゼプリル」 |
関連記事 | 「hydrochloride」 |
.